THE LIFESTYLE FIX: What Actually Lowers Heart Attack and Stroke Risk?

If Edition #022 helped answer “How much cardiovascular risk do I actually have?”, the next question is: what can I do about it with lifestyle?

The biggest lever depends on what is abnormal. If you smoke, stopping comes before optimizing olive oil. If blood pressure is 150/95, that matters more than whether you eat oats or berries. If LDL-C or ApoB is high, diet should specifically target it. If you carry excess abdominal fat and have poor fitness, body composition and activity become major treatment targets.

Lifestyle works best when it is targeted: identify the cardiovascular exposures you actually have, use the intervention most likely to change them, then measure whether they moved.

If you smoke, quitting is one of the highest-return cardiovascular interventions available. In a 2022 Cochrane review, people with cardiovascular disease who quit had about one-third fewer recurrent cardiovascular events than those who continued smoking.[1] In a randomized trial of high-risk smokers with cardiovascular disease, an intensive cessation program also increased verified abstinence and reduced hospitalizations and all-cause mortality over two years.[2]

Blood pressure is another major lever. Across randomized treatment trials, lowering systolic pressure by 5 mmHg was associated with about a 10% reduction in major cardiovascular events.[3] Lifestyle reductions cannot be assigned the exact same effect, but this shows why elevated BP deserves priority.

High LDL-C and a high burden of ApoB-containing particles are major causal drivers of atherosclerosis. Lifestyle can improve both. Edition #024 will focus on LDL-C and ApoB together: how low they should go, why the markers can disagree, and what to do when lifestyle does not lower them enough.

Excess abdominal fat, poor fitness, insulin resistance, high triglycerides and rising glucose also reinforce one another. Diet, exercise and body composition should not be treated as separate boxes.

Energy intake and physical activity influence total and visceral fat. Visceral fat around the organs contributes to hypertension, insulin resistance, diabetes, abnormal triglyceride-rich lipoproteins and inflammation.

That is why waist matters alongside weight. The 2026 cardiovascular-kidney-metabolic guideline recommends assessing BMI and waist together and uses 5% to 10% weight loss as a meaningful initial target for people with overweight or obesity.[4]

But scale weight can miss progress. A meta-analysis of 117 studies found about a 6% reduction in visceral fat with exercise even in studies without weight loss.[5]

So if excess abdominal fat is present, the target is not simply “weigh less.” It is less excess abdominal fat, better fitness, preserved muscle and better risk markers.

Diet influences body composition, but food quality can also change blood pressure, LDL-C/ApoB, triglycerides and glucose without major weight loss.

Randomized outcome trials support a Mediterranean-style pattern built around vegetables, fruit, legumes, nuts, whole grains, olive oil, fish and seafood, with poultry and other lean proteins fitting in while red and processed meat stay lower. In PREDIMED, the adherence pattern encouraged fish or shellfish at least three times per week and favored poultry over red or processed meat.[6]

In the revised PREDIMED analysis, high-risk adults assigned to Mediterranean diets had fewer major cardiovascular events.[7] PREDIMED had protocol problems, but CORDIOPREV, a separate randomized trial in coronary disease, also favored a Mediterranean diet over a low-fat diet.[8]

Use that as a base, then target the abnormality.

If LDL-C/ApoB is high, emphasize unsaturated-fat foods, soluble fiber, legumes and nuts. Soluble fiber (psyllium, oats/oat bran, barley) can lower both.[9]

If blood pressure is high, a DASH-style diet can help. Across 30 randomized trials, DASH lowered systolic pressure by about 3.2 mmHg and diastolic pressure by 2.5 mmHg versus controls.[10]

If triglycerides, glucose and abdominal fat are the problem, total calories, refined carbohydrates, alcohol and activity become more important targets.

This builds on the food-quality problem in Edition #004, Ultra-Processed Foods and the fat-quality discussion in Edition #021.

The largest gain appears to come from going from inactive to active.

A dose-response analysis covering more than 30 million people found progressively lower cardiovascular and mortality risk as activity increased, with the steepest improvement before roughly 150 minutes per week of moderate-to-vigorous activity.[11]

Higher cardiorespiratory fitness is also consistently associated with lower cardiovascular disease and mortality.[12] Exercise also reduces visceral fat, improves insulin sensitivity and blood pressure, and preserves muscle. Resistance training complements aerobic work, especially during weight loss.

The deeper exercise playbook is covered in vigorous movement (Edition #001), cardiorespiratory fitness (Edition #012) and resistance training (Edition #006).

Look AHEAD randomized more than 5,000 adults with overweight or obesity and type 2 diabetes to intensive lifestyle weight loss or diabetes education. After nearly a decade, the lifestyle group improved weight, fitness, glucose and several risk factors, but not major cardiovascular events.[13]

That does not mean obesity or weight loss do not matter. By the end, weight loss was about 6.0% versus 3.5% in controls, leaving only a modest long-term difference between groups, and LDL-C did not improve more in the lifestyle group.

The narrower lesson is that modest weight loss does not guarantee a detectable event reduction in every trial. Excess abdominal fat remains a cardiovascular target, and larger sustained losses generally produce larger cardiometabolic improvements.[4]

Some medical obesity treatments produce substantially greater weight loss and have reduced cardiovascular events. They are not lifestyle interventions, so GLP-1-based and other obesity treatments deserve a future MED Report edition (stay tuned!).

Alcohol should not be used as heart medicine. The apparent protection with light or moderate drinking weakens after accounting for confounding, while genetic evidence points toward increasing cardiovascular risk as intake rises.[14] If intake is high, reducing it becomes a major priority, consistent with the dose-response picture covered in Edition #013.

Sleep and chronic stress matter too, but as supporting levers. Persistent high stress is associated with higher coronary risk, and psychological interventions have reduced some cardiac outcomes in people with established cardiovascular disease.[15,16] Sleep and stress also affect blood pressure, appetite, glucose and adherence. The practical sleep intervention is covered in Edition #011.

Lifestyle can materially reduce cardiovascular risk, but “living healthy” is not a treatment plan.

Find the major modifiable risks you actually have. Apply enough lifestyle intervention to move them. Then verify that they moved.

REMOVE OR REDUCE THE BIG HARMS: If you smoke, quitting is priority one. If alcohol intake is high, reducing it also moves near the top. There is no cardiovascular reason to start drinking.

TARGET: Attack the biggest abnormality identified in Edition #022: blood pressure, LDL-C/ApoB, excess abdominal fat/metabolic dysfunction or poor fitness.

MOVE: Build toward at least 150 minutes per week of moderate aerobic activity, plus strength training at least twice per week.[17]

EAT: Use a minimally processed, high-fiber Mediterranean-style pattern as the base, then modify it for the risk factor you are targeting.

LEAN OUT: If you carry excess abdominal fat, reduce waist and weight while maintaining or building muscle and fitness. A 5% to 10% initial weight-loss target is meaningful, not a magic finish line.

RECOVER: Get adequate sleep and actively address persistent high stress.

MEASURE: Track waist, blood pressure and fitness. Recheck abnormal blood markers after roughly 8 to 12 weeks.

Don’t just collect healthy habits. Use targeted lifestyle interventions that actually move the needle on your cardiovascular risk factors, then measure whether they worked.

If LDL-C or ApoB remains higher than it should be despite the lifestyle work, Edition #024 picks up there.

Subscribe free — one edition in your inbox every Wednesday. No spam. No conflicts of interest. Any future sponsorships will be clearly disclosed and personally vetted.

After subscribing, check your junk/spam folder for the confirmation email and mark it as ‘Not Spam’ to ensure delivery.

1. Wu AD, Lindson N, Hartmann-Boyce J, et al. Smoking cessation for secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2022;8:CD014936. https://pubmed.ncbi.nlm.nih.gov/35938889/

2. Mohiuddin SM, Mooss AN, Hunter CB, et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest. 2007;131(2):446-452. https://pubmed.ncbi.nlm.nih.gov/17296646/

3. Blood Pressure Lowering Treatment Trialists' Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625-1636. https://pubmed.ncbi.nlm.nih.gov/33933205/

4. Ndumele CE, Rodriguez F, Dixon DL, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome. Circulation. 2026;154(4):e50-e158. https://pubmed.ncbi.nlm.nih.gov/42263157/

5. Verheggen RJHM, Maessen MFH, Green DJ, et al. A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev. 2016;17(8):664-690. https://pubmed.ncbi.nlm.nih.gov/27213481/

6. Ros E, Martínez-González MA, Estruch R, et al. Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study. Adv Nutr. 2014;5(3):330S-336S. https://pubmed.ncbi.nlm.nih.gov/24829485/

7. Estruch R, Ros E, Salas-Salvadó J, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N Engl J Med. 2018;378(25):e34. https://pubmed.ncbi.nlm.nih.gov/29897866/

8. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet. 2022;399(10338):1876-1885. https://pubmed.ncbi.nlm.nih.gov/35525255/

9. Ghavami A, Ziaei R, Talebi S, et al. Soluble Fiber Supplementation and Serum Lipid Profile: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2023;14(3):465-474. https://pubmed.ncbi.nlm.nih.gov/36796439/

10. Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary Approaches to Stop Hypertension (DASH) Diet and Blood Pressure Reduction in Adults with and without Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2020;11(5):1150-1160. https://pubmed.ncbi.nlm.nih.gov/32330233/

11. Garcia L, Pearce M, Abbas A, et al. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies. Br J Sports Med. 2023;57(15):979-989. https://pubmed.ncbi.nlm.nih.gov/36854652/

12. Lang JJ, Prince SA, Merucci K, et al. Cardiorespiratory fitness is a strong and consistent predictor of morbidity and mortality among adults: an overview of meta-analyses representing over 20.9 million observations from 199 unique cohort studies. Br J Sports Med. 2024;58(10):556-566. https://pubmed.ncbi.nlm.nih.gov/38599681/

13. Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145-154. https://pubmed.ncbi.nlm.nih.gov/23796131/

14. Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open. 2022;5(3):e223849. https://pubmed.ncbi.nlm.nih.gov/35333364/

15. Richardson S, Shaffer JA, Falzon L, et al. Meta-analysis of perceived stress and its association with incident coronary heart disease. Am J Cardiol. 2012;110(12):1711-1716. https://pubmed.ncbi.nlm.nih.gov/22975465/

16. Nie Y, Wang N, Chi M, et al. Effects of psychological interventions on clinical outcomes in patients with cardiovascular diseases: A systematic review and meta-analysis. J Psychosom Res. 2024;187:111938. https://pubmed.ncbi.nlm.nih.gov/39321711/

17. Piercy KL, Troiano RP, Ballard RM, et al. The Physical Activity Guidelines for Americans. JAMA. 2018;320(19):2020-2028. https://pubmed.ncbi.nlm.nih.gov/30418471/

Evidence disclosure: PREDIMED was primarily publicly funded but received donated olive oil and nuts, and some investigators reported food-industry relationships. CORDIOPREV reported support that included olive-oil-related foundations. PREDIMED was withdrawn and republished after randomization/protocol deviations were identified; the revised 2018 analysis is cited above.